Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BERLIN, Germany and SEATTLE, May 11, 2006 (PRIMEZONE) -- The German biotech company Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX) announced today that the company will be presenting at the 3rd...
-
BERLIN and SEATTLE, May 3, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported financial...
-
BERLIN and SEATTLE, April 5, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today presented data...
-
BERLIN, April 3, 2006 (PRIMEZONE) -- Epigenomics AG Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today confirmed that...
-
BERLIN, Germany and SEATTLE, March 24, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today...
-
BERLIN and SEATTLE, March 22, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Other OTC:EPGNF), a molecular diagnostics company developing tests based on DNA methylation, announced today an...
-
BERLIN and SEATTLE, March 17, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Other OTC:EPGNF) will hold a press conference and analyst meeting on March 24, 2006 to present results for the fiscal...
-
BERLIN and SEATTLE, Jan. 30, 2006 (PRIMEZONE) -- Epigenomics AG (Other OTC:EPGNF) (Frankfurt:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that Roche...
-
BERLIN and SEATTLE, Jan. 4, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today the...
-
BERLIN and SEATTLE, Jan. 4, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today the...